Trying to separate three different claims about semaglutide: that it is the right molecule, that it is the right dose, and that it does something useful.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Baseline first. Without a baseline the after picture is decoration.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Sulphur burps and nausea for the first weeks are the usual complaint and they do fade.
What would change your mind about this?
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at. Nausea was my main issue with semaglutide too.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing. How long have you been on semaglutide?
Read methods. Nausea was my main issue with semaglutide too.
Same here.
Same here.
Nobody has ever been talked out of a stack by a stranger on the internet. Not on semaglutide but the pattern is familiar.
Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.
Loose evidence and no evidence are different, and people overcorrect in both directions. Three years in on semaglutide and it lines up.
What is the first thing you would read if you were starting from zero?
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take. Currently on semaglutide myself.
Is a baseline blood test really necessary before starting something like this?
Test one thing at a time. It feels slower and it is the only way to learn anything. Same for me with semaglutide, unfortunately.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.